ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.497,94
-0,09%
S&P 500
5.234,89
-0,01%
Dow Jones
38.406,63
0,77%
Euro vs US Dollar
1,08447
0,12%
Bitcoin
67.397,06
-1,41%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. HOOKIPA Pharma Inc (HOOK)

  7. HOOKIPA Pharma Inc (HOOK) News

HOOK

HOOKIPA Pharma (HOOK)

HOOKIPA Pharma Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:HOOK
DatumZeitQuelleÜberschriftSymbolFirma
30/05/202422h30GlobeNewswire Inc.HOOKIPA Pharma to Host Investor Call on HB-200 Data Presented at American Society of Clinical Oncology 2024 Annual MeetingNASDAQ:HOOKHOOKIPA Pharma Inc
23/05/202423h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HOOKHOOKIPA Pharma Inc
23/05/202423h01GlobeNewswire Inc.HOOKIPA Pharma Announces Positive Clinical Data to be Presented at the American Society for Clinical Oncology 2024 Annual MeetingNASDAQ:HOOKHOOKIPA Pharma Inc
09/05/202413h04Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:HOOKHOOKIPA Pharma Inc
09/05/202413h03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HOOKHOOKIPA Pharma Inc
09/05/202413h01GlobeNewswire Inc.HOOKIPA Pharma Reports First Quarter 2024 Financial Results and Recent Business HighlightsNASDAQ:HOOKHOOKIPA Pharma Inc
25/04/202413h01GlobeNewswire Inc.HOOKIPA Pharma Announces Pivotal Phase 2/3 Trial Design for HB-200 in Combination with PembrolizumabNASDAQ:HOOKHOOKIPA Pharma Inc
24/04/202413h01GlobeNewswire Inc.HOOKIPA Pharma Announces FDA Clearance of its Investigational New Drug Application for HB-700 for the Treatment of KRAS-Mutated CancersNASDAQ:HOOKHOOKIPA Pharma Inc
16/04/202422h30GlobeNewswire Inc.HOOKIPA Pharma Announces Grant of Inducement Award Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:HOOKHOOKIPA Pharma Inc
10/04/202413h01GlobeNewswire Inc.HOOKIPA Pharma to Host Investor Call on HB-200 and Planned Path to RegistrationNASDAQ:HOOKHOOKIPA Pharma Inc
22/03/202412h01GlobeNewswire Inc.HOOKIPA Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business HighlightsNASDAQ:HOOKHOOKIPA Pharma Inc
06/03/202413h01GlobeNewswire Inc.HOOKIPA Pharma to Participate in Leerink Partners Global Biopharma ConferenceNASDAQ:HOOKHOOKIPA Pharma Inc
31/01/202422h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HOOKHOOKIPA Pharma Inc
29/01/202414h12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HOOKHOOKIPA Pharma Inc
29/01/202414h01GlobeNewswire Inc.HOOKIPA Pharma Provides Update on Business Priorities and Oncology Partnership ProgramsNASDAQ:HOOKHOOKIPA Pharma Inc
16/01/202413h01GlobeNewswire Inc.HOOKIPA Pharma Appoints Mark Winderlich as Chief Development Officer to Lead Clinical Research and Development OrganizationNASDAQ:HOOKHOOKIPA Pharma Inc
05/01/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:HOOKHOOKIPA Pharma Inc
22/12/202313h33Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:HOOKHOOKIPA Pharma Inc
21/12/202313h06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HOOKHOOKIPA Pharma Inc
21/12/202313h01GlobeNewswire Inc.HOOKIPA Pharma Announces $21.25 Million Equity Investment from Gilead SciencesNASDAQ:HOOKHOOKIPA Pharma Inc
01/12/202322h46Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HOOKHOOKIPA Pharma Inc
20/11/202313h01GlobeNewswire Inc.HOOKIPA Pharma Announces FDA Clearance of its Investigational New Drug Application for HB-500 for the Treatment of Human Immunodeficiency VirusNASDAQ:HOOKHOOKIPA Pharma Inc
09/11/202313h10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:HOOKHOOKIPA Pharma Inc
09/11/202313h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HOOKHOOKIPA Pharma Inc
09/11/202313h01GlobeNewswire Inc.HOOKIPA Pharma Reports Third Quarter 2023 Financial Results and Recent Business HighlightsNASDAQ:HOOKHOOKIPA Pharma Inc
03/11/202317h01GlobeNewswire Inc.HOOKIPA Pharma Presents Positive Biomarker and Translational Data on HB-200 Monotherapy at Society for Immunotherapy of Cancer 2023NASDAQ:HOOKHOOKIPA Pharma Inc
02/11/202321h01GlobeNewswire Inc.HOOKIPA Pharma to Report Third Quarter 2023 Financial Results and Recent Business Highlights on November 9, 2023NASDAQ:HOOKHOOKIPA Pharma Inc
22/10/202312h01GlobeNewswire Inc.HOOKIPA Pharma Presents Additional Preliminary Phase 2 Data on HB-200 in Combination with Pembrolizumab as First-Line Treatment in Patients with HPV16+ Head and Neck Cancers at European Society for Medical Oncology Congress 2023NASDAQ:HOOKHOOKIPA Pharma Inc
20/10/202322h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HOOKHOOKIPA Pharma Inc
18/10/202313h01GlobeNewswire Inc.HOOKIPA Pharma announces publication of preclinical data of hepatitis B virus (HBV) therapeutic vaccine developed in collaboration with Gilead SciencesNASDAQ:HOOKHOOKIPA Pharma Inc
 Showing the most relevant articles for your search:NASDAQ:HOOK

Kürzlich von Ihnen besucht

TSXV
KLH
Stellar Biotechnologies, Inc.
ASX
CUF
CuFe
TG
3EG
Endurance Gold
COIN
BUSYUSD
Busy
NASDAQ
ZIONW
Zions Bancorporation NA
NASDAQI
ONEQT
Fidelity Nasdaq Composite
TG
9AX
Axalta Coating Systems
NASDAQ
REMY
GDAX
CRPTUSD
Crypterium
USOTC
KASHF
Intellabridge Technology (QB)
ASX
QUAL
VanEck Investments
LSE
HSXU
Hsbc Eur Exuksu
COIN
$ANRXUSD
AnRKey X
TG
LC8
Calliditas Therapeutics AB
LSE
MF28
Sog_.gdaxi_mf28
USOTC
IMXCF
IMAX China (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten